|
시장보고서
상품코드
2077247
바큘로바이러스 발현 시스템 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별Baculovirus Expression System Market, By Product Type, By Application, By End User, By Geography |
||||||
바큘로바이러스 발현 시스템 시장은 2026년에 4억 7,480만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 8억 6,240만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.9%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 4억 7,480만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 8.90% | 예측 금액(2033년) | 8억 6,240만 달러 |
바큘로바이러스 발현 시스템은 재조합 단백질 생산에 있어 생명공학 분야에서 매우 범용성이 높으며, 널리 활용되고 있는 도구입니다. 바큘로바이러스는 곤충 세포에 감염되는 곤충 바이러스로, 목표하는 외래 유전자가 발현되도록 유전자 조작이 이루어져 있습니다. 이 시스템은 다른 발현 시스템에 비해 높은 단백질 수율, 번역 후 변형, 확장성 등 몇 가지 장점이 있습니다.
바큘로바이러스 발현 시스템은 바이오의약품 제조, 단백질 연구, 백신 개발, 유전자 치료 등 다양한 분야에서 활용되고 있습니다. 이 시스템은 오랜 기간에 걸쳐 광범위하게 연구 및 최적화가 진행되어 왔으며, 효율성과 범용성을 높이기 위해 노력해 왔습니다.
시장 역학:
세계 바큘로바이러스 발현 시스템 시장은 향후 몇 년 동안 상당한 성장이 예상됩니다. 이러한 성장을 이끄는 요인으로는 치료 및 연구 목적으로 사용되는 재조합 단백질에 대한 수요 증가 등을 들 수 있습니다. 이 시스템은 복잡하고 기능적인 단백질을 대량으로 생산할 수 있는 능력을 갖추고 있어, 바이오의약품 업계에서 선호되는 선택지로 자리 잡고 있습니다.
시장의 또 다른 성장 동력은 새로운 치료법과 백신 개발을 위한 연구개발 활동에 대한 투자가 증가하고 있다는 점입니다. 바큘로바이러스 발현 시스템은 이러한 생물학적 제제를 생산하기 위한 신뢰성이 높고 비용 대비 효과가 뛰어난 플랫폼을 제공합니다.
그러나 시장에는 일정한 제약도 존재합니다. 주요 과제 중 하나는 바큘로바이러스 발현 시스템을 이용한 단백질 생산 공정이 복잡하고 시간이 오래 걸린다는 점입니다. 시스템 최적화나 확장에는 기술적 전문 지식이 필요하며, 막대한 노력이 소요될 가능성이 있습니다.
그럼에도 불구하고, 이 시장에는 수많은 성장 기회가 존재합니다. 맞춤형 의료에 대한 관심이 높아지고, 첨단 치료법 개발이 진전됨에 따라 맞춤형 단백질 생산 시스템에 대한 수요가 생겨나고 있습니다. 유연성을 갖추고 광범위한 단백질을 생산할 수 있는 바큘로바이러스 발현 시스템은 이러한 수요에 부응하기에 가장 적합한 위치에 있습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 전 세계 바큘로바이러스 발현 시스템 시장의 주요 기업 프로파일을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록했습니다.
- 본 보고서에서 다루고 있는 주요 기업으로는 Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek 등이 포함됩니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 바큘로바이러스 발현 시스템 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 바큘로바이러스 발현 시스템 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 바큘로바이러스 발현 시스템 시장
제5장 세계의 바큘로바이러스 발현 시스템 시장 : 제품 유형별(2021-2033년)
제6장 세계의 바큘로바이러스 발현 시스템 시장 : 용도별(2021-2033년)
제7장 세계의 바큘로바이러스 발현 시스템 시장 : 최종 사용자별(2021-2033년)
제8장 세계의 바큘로바이러스 발현 시스템 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
JHS 26.07.13Baculovirus Expression System Market is estimated to be valued at USD 474.8 Mn in 2026 and is expected to reach USD 862.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 474.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 862.4 Mn |
A baculovirus expression system is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculovirus is an insect virus that infects insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems including high protein yields, post-translational modifications, and scalability.
The baculovirus expression system has found applications in various fields such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.
Market Dynamics:
The global baculovirus expression system market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.
Another driver of the market is the rising investments in research and development activities for the development of novel therapies and vaccines. The baculovirus expression system provides a reliable and cost-effective platform for the production of these biologics.
However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the baculovirus expression system. The optimization and scaling-up of the system requires technical expertise and can be labor-intensive.
Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics creates a demand for customized protein production systems. The baculovirus expression system, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- Key players in the global baculovirus expression system market are profiled including company highlights, product portfolios, key highlights, financial performance, and strategies
- The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek
- Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
- The global baculovirus expression system market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would benefit from the strategy matrices used in analyzing the global baculovirus expression system market, making decision-making easier
Global Baculovirus Expression System Market Segmentation:
- By Product Type (Revenue, USD Mn, 2021 - 2033)
- Baculovirus
- Expression Vector
- Reagents
- Others
- By Application (Revenue, USD Mn, 2021 - 2033)
- Therapeutics
- Vaccines
- Protein Purification
- Others
- By End User (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Research Institutes
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Baculovirus Expression System Market:
- Thermo Fisher Scientific
- Merck KGaA
- Takara Bio
- Agilent Technologies
- Oxford Expression Technologies
- Promega Corporation
- Qiagen N.V.
- Bio-Rad Laboratories
- New England Biolabs
- Genscript Biotech Corporation
- Syngene International Limited
- Sartorius AG
- Aragen Bioscience
- Vivopure
- Creative Biogene
- Absolute Antibody
- Rockland Immunochemicals
- Protein Technologies, Inc. (PTI)
- Proteogenix
- Virovek
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Baculovirus Expression System Market, By Product Type
- Global Baculovirus Expression System Market, By Application
- Global Baculovirus Expression System Market , By End User
- Global Baculovirus Expression System Market , By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- The increasing demand for recombinant proteins for therapeutic and research purposes
- Restraints
- The complex and time-consuming process of protein production
- Opportunities
- The increasing focus on personalized medicine and the development of advanced therapeutics
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global Baculovirus Expression System Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Baculovirus Expression System Market, By Product Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Baculovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Expression Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Baculovirus Expression System Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Protein Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Baculovirus Expression System Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Global Baculovirus Expression System Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
- U.K
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2021 - 2033, (US$ Mn)
- GCC
- IsraelNorth Africa
- Central Africa
- South Africa
- Rest of Middle East & Africa
9. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oxford Expression Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genscript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Syngene International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aragen Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vivopure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Absolute Antibody
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Rockland Immunochemicals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Protein Technologies, Inc. (PTI)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Proteogenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Virovek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
